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creativecommons.org/licenses/by/4.0/).Turner’s syndrome is a disorder deﬁned by an absent or structurally abnormal second X
chromosome and affects around 1 in 2000 newborn females. The standardised mortality ratio
in Turner’s syndrome is around three-times higher than in the general female population,
mainly as a result of cardiovascular disorders. Most striking is the early age at which Turner’s
syndrome patients develop the life-threatening complications of cardiovascular disorders
compared to the general population. The cardiovascular risk stratiﬁcation in Turner’s syn-
drome is challenging and imaging is not systematically used. The aim of this article is to review
cardiovascular risks in this group of patients and discuss a systematic imaging approach for
early identiﬁcation of cardiovascular disorders in these patients.
 2015 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.
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4.0/).Introduction
Turner’s syndrome (TS) or UllricheTurner’s syndrome is
a disorder deﬁned by an absent or structurally abnormal
second X chromosome and affects around 1 in 2000
newborn females.1 The variable phenotypes can be split
into three main categories: monosomy X karyotype (45,X)
(in 36e45%); mosaic karyotype (44e54%); and an isochro-
mosome Xq, (5e11%).2,3 Short stature, gonadal dysgenesis,
and congenital cardiovascular defects are common features
of TS.4 Congenital heart defects, such as hypoplastic leftClinical Research Imaging
iversity of Edinburgh, 47
el.: þ44 131 2427768; fax:
. Mirsadraee).
er Ltd on behalf of The Royal Colleheart syndrome and/or hypoplastic aortas, are the major
causes of prenatal mortality.5e7 The foetuses with less se-
vere cardiovascular defects survive the ﬁrst trimester and
can be recognised by in-utero ultrasound by hydrops of the
trunk and limbs, large and loculated cystic hygromas of the
posterolateral neck, pleural effusions, and ascites.6 When
these resolve they leave the postnatal webbing of the neck
(pterygium colli), puffy hands and feet, or redundant nuchal
skin, making the diagnosis possible in 20e30% of newborn
girls with TS.4 Around one-third are diagnosed in mid-
childhood on the investigation of short stature and broad
chest. In most other patients, who have milder signs and
symptoms of TS, the condition is diagnosed due to delayed
or absent pubertal development secondary to gonadal
dysgenesis either in adolescence or in adulthood.4 The most
common cardiovascular defects in surviving TS patients are
bicuspid aortic valve (BAV) and aortic coarctation. Thesege of Radiologists. This is an open access article under the CC BY license (http://
A. Marin et al. / Clinical Radiology 70 (2015) 803e814804patients are also at increased risk for hyperlipidaemia, hy-
pertension, and atherosclerosis.8
The age-speciﬁc death rate in TS is around three-times
higher than in the general female population with Fig 1
tabulating the relative standardised mortality ratios
(SMRs).2,3 Cardiovascular disease accounts for 41% of excess
deaths and the relative risk is most markedly elevated with
cardiovascular congenital anomalies; in particular BAV and
aortic aneurysm.3 The risk of acquired aortic dissection is
increased by up to 100-fold and can occur in TS patients as
young as 16e18 years.9,10
The above highlights the need for appropriate cardio-
vascular risk stratiﬁcation in TS patients. In the UK and
some other countries, dedicated TS clinics have been
established where teams of paediatric endocrinologists,
gynaecologists, cardiologists, radiologists, and hypertension
specialists are implementing appropriate screening and
management strategies.8,11 The aim of this paper is to re-
view the role of clinical imaging in TS cardiovascular risk
stratiﬁcation.
Methodology
Literature search
Publications were identiﬁed by a systematic literature
search using PubMed to identify studies evaluating medical
issues in TS published between January 1990 and August
2014. The search terms used in the Medical Subject Head-
ings (MeSH) Database were "Turner Syndrome/Figure 1 Total and cause-speciﬁc SMR in Turner’s syndrome by main dia
data. SMR is the ratio of deaths in the study population compared with th
study used the ICD-10, while the study from Great Britain used ICD-9 for
subcategories (e.g., diseases of musculoskeletal system, aortic valve diseas
separately included in the Danish cohort study data. The high congenital a
of the heart and great arterial vessels.complications"[Mesh] OR "Turner Syndrome/etiology"[-
Mesh] OR "Turner Syndrome/mortality"[Mesh] OR "Turner
Syndrome/radiography"[Mesh] OR "Turner Syndrome/
ultrasonography"[Mesh] OR 00Turner Syndrome/imag-
ing"[Mesh] OR "Turner Syndrome/cardiovascular"[Mesh]
OR "Turner Syndrome/congenital"[Mesh]. Out of the 1242
papers found, 82 met the selection criteria. Only full-length
original articles were included. Non-English texts, experi-
mental studies, and case series with fewer than ﬁve patients
were excluded. In addition, the references were revised and
eligible articles that were not captured by the search
strategy were identiﬁed.
Congenital cardiovascular disorders and
complications
Cardiovascular anomalies (Table 1) are present in up to
50% of the TS population and are the major cause of pre-
mature mortality.3,9,10,12e15 The most commonly occurring
cardiovascular anomalies are a BAV, aortic dilatation, elon-
gation of the thoracic arch, aortic coarctation, and partial
anomalous pulmonary venous return.
Pathogenesis
The pathogenesis of these cardiovascular defects is still
unclear. Previously, it was thought that the left heart
outﬂow tract defects were caused by increased fetal
lymphatic pressure and jugular lymphatic sac obstruction
leading to obstruction to or reduction of the blood ﬂowgnostic groups, from the Denmark2 and Great Britain3 cohort studies
e number expected from rates in the general population. The Danish
the classiﬁcation of diagnostic groups. Some cause-speciﬁc diagnostic
e, cardiovascular congenital anomalies and aortic aneurysm) were not
nomalies SMR in Danish cohort is likely attributable to malformations
Table 1
The imaging ﬁndings of the associated congenital anomalies and acquired diseases in Turner’s syndrome.
System Congenital anomaly or acquired disease Frequency/risk Occurs in combination with
Cardiovascular Bicuspid aortic valve 30%22 (versus 1e2% in general
population)21,22
Aortic coarctation, neck webbing17
Aortic dilatation 32e42%15,39,40 BAV, aortic coarctation, hypertension or
independently
Aortic dissection 100-fold increased risk, 36 cases/100,000
patient years
(versus 6/100,000 in general population)9
BAV, aortic coarctation, hypertension
Aortic coarctation 10e12%12,69 BAV, neck webbing17
Elongated transverse arch 49%12
Partial anomalous pulmonary venous return 13%57
Ischaemic heart disease 50%, appearing 6e13 years earlier than
expected20
Arterial hypertension, hyperlipidaemia
Skeletal Osteoporosis 10e50%70e72 Prolonged hypogonadism
Bone fractures 5e45%70,72 Osteoporosis
Cervical vertebral hypoplasia
Scoliosis 5e10%73 Growth hormone therapy
Cubitus valgus Up to 50%
Genu valgum 60%74
Short metacarpals and metatarsals
“Bayonet deformity” or Madelung’s deformity
Renal Horseshoe kidney, duplex systems, and long
posteriorly rotated kidneys
33e38%75,76
Reproductive Gonadal dysgenesis 90% require hormone-replacement therapy4
A. Marin et al. / Clinical Radiology 70 (2015) 803e814 805within the developing heart, resulting in the observed left
heart defects. This hypothesis also encompassed the
development of anomalous pulmonary venous drainage
due to the hold-up of blood ﬂow within the pulmonary bed
secondary to the left heart defects.16 However, more
recently published papers have demonstrated the presence
of aortic coarctation and BAVs in TS without evidence of
fetal lymphoedema, and that the presence of partial
anomalous pulmonary venous return is not associated with
either aortic coarctation or BAV, both observations in
contradiction to the original hypothesis.17,18 Miyabara19 and
colleagues suggest an alternative idea, that a primary neural
crest defect in the region responsible for the formation of
the 4th pharyngeal pouch and 4th branchial branch was
responsible for both the congenital heart and lymphatic
anomalies. Regardless of the exact embryological trigger for
the developmental anomalies in TS, presuming a single
trigger can account for all of the anomalies, great leaps have
been made in the understanding of the genetic de-
terminants of congenital heart defects. Cardiovascular de-
fects, aortic aneurysm, and dissection are most frequently
observed among TS patients with 45,X karyotype, with a
high prevalence of congenital heart defects also present in
TS females missing only the X chromosome short arm,
meaning that haplo-insufﬁciency for Xp genes contributes
to the abnormal aortic valve and aortic arch development in
TS.3,18,20 In the future, this knowledge may allow a more
targeted identiﬁcation of those most likely to beneﬁt from a
more detailed or intensive investigation programme.
Clinical presentations
BAV is the most common congenital cardiovascular
malformation occurring in up to 30% of TS patients
compared with just 1e2% in the general population(Fig 2).21,22 Individuals with BAV are at increased risk of
aortic coarctation and/or aortic dilatation.22 BAV at a young
age is usually clinically silent, but with age BAV tends to
more rapidly degenerate and calcify, resulting in progres-
sive stenosis and/or regurgitation (Fig 3).23,24 In 95% of adult
TS females, BAV is a consequence of fusion of the right and
left coronary leaﬂets (R-L BAV), while the fused right coro-
nary and non-coronary leaﬂets (ReNC BAV) variant is much
less common.22 However, a single study of post-mortem
heart specimens from 36 TS fetuses and one TS newborn
reported a larger proportion of R-NC BAV type (31%).25 The
pattern of aortic valve leaﬂet fusion in patients with BAV
may be important, because general population studies have
demonstrated that the R-NC BAV is associated with a higher
prevalence of signiﬁcant aortic valve stenosis and regurgi-
tation, whereas the R-L BAV is associated with aortic
coarctation, dilatation, and less frequently with aortic valve
pathology.26,27 Both a genetic and ﬂow-mediated hypoth-
esis have been proposed for the association between BAV
and aortopathy.28 The genetic model proposes that a dis-
order in one of the genes responsible for vascular connec-
tive tissue development is responsible for both BAV
formation and the subsequent propensity for aortic dilata-
tion. However, a growing body of evidence demonstrates an
abnormal eccentric ﬂow pattern, which is directed at the
lateral ascending aortic wall in those with R-L fusion,
resulting inwall remodelling secondary to elevated regional
wall shear stress even where there is no signiﬁcant trans-
valvular gradient or regurgitation.29e31
The role of imaging in BAV is for the detection of fused
leaﬂets, the characterisation of the location of the fusion
and the quantiﬁcation of valvular function. Transthoracic
two-dimensional and colour Doppler echocardiography
enables a reliable non-irradiating assessment of the
Figure 2 Systolic cine MRI of the BAV in two patients with TS. (a) Demonstrates a R-L BAV (arrow) and (b) demonstrates a R-L BAV (arrow) with
raphe (arrowhead).
A. Marin et al. / Clinical Radiology 70 (2015) 803e814806cardiovascular anatomy including the aortic valve and root
and the ascending part of the thoracic aorta, as well as
providing accurate assessment of valvular function.32
However, transthoracic echocardiography can be inade-
quate in visualising the aortic valve in TS in around 6%, with
BAV itself as a risk factor for non-visualisation of the aortic
valve.33 Other factors for suboptimal visualisation of the
aortic valve with transthoracic echocardiography are calci-
ﬁcation of the valve and a poor acoustic window (associated
with obesity and short stature, both common occurrences
in women with TS).34,35 In these instances, cardiac MRI is
useful for further evaluation of the anatomy of the valve
using balanced steady-state free precession (bSSFP) cine
sequence to visualise the valve, with phase-contrast MRI for
functional assessment. MRI typically underestimates the
severity of aortic stenosis compared with echocardiography
due to ﬂow vorticity causing signal loss. However, MRI isFigure 3 Systolic bSSFP cine MRI of the aortic valve (a), the aortic root (b)
stenosis and aortic regurgitation on transthoracic echocardiography, which
demonstrates a L-R BAV (arrow), and (b) the three-chamber view shows a
root and ascending aorta in sagittal oblique (diameter measurements whit
of the main pulmonary artery.associated with less inter-scan and interobserver
variability.36e38
Aortic dilatation is reported in 32e42% of women with
TS.15,39,40 Table 2 summarises the studies on aortic dilata-
tion in Turner’s syndrome. Aortic dilatation may occur in
isolation. However, it is most commonly found in associa-
tion with BAV and/or aortic coarctation, with one study
showing BAV to be present in 85% of those with aortic
dilatation.13,41 Given that age and body size are strongly
predictive of aortic diameter, use of standard absolute
values for the evaluation and diagnosis of aortic dilatation
in TS, with its abnormal body posture, is grossly inaccu-
rate.42 Comparison with normograms derived from age-
matched women is also ﬂawed for the same reason.43 The
use of an ascending/descending aortic diameter (AD/DD)
ratio circumvents some of these issues as it provides an
individualised normative value against which to compareand ascending aorta (c,d) in a 45-year-old TS patient with mild aortic
was unable to assess the aortic dimensions. (a) Atrioventricular view
n asymmetric jet ﬂow through the BAV (arrow). (c) Shows the aortic
e lines) and left bottom ﬁgure (white frame) in axial views at the level
Table 2
Summary of studies looking at MRI assessment of aortic dilatation and dissection in Turner’s syndrome.
Study No Sequence Measurements Findings
Aortic dilatation
Dawson-Falk 199277 40 ECG-gated T1W “black blood”
TSE sequence
Axial stack through aorta with diameter
measured on slice with most dilated aorta
Aortic dilation in 12.5 exed diameter >95th CI based
on CT values). 80% of were only seen on MRI
Castro 200278 15 ECG-gated T1W “black blood”
TSE sequence
Axial stack through aorta with diameter
measured 1 cm above aorta root
Ascending aortic dilat 40% (indexed diameter
>95th CI based on CT s); 26.7% had AD:DD >1.5
Ostberg 200439 115 No details Ascending and descending aorta at level
of right pulmonary artery
Ascending aorta dilat 33% using MRI criteria (AD:DD
>1.5), but only 7% me h MRI and echocardiography
criteria for dilatation. ed root associated with age and BAV
Chalard 200565 21 ECG-gated T1W “black blood”
TSE sequence
Two axial slices producing four measurements 19% (n ¼ 5) had ascen aortic dilatation (not deﬁned)
Ilyas 200679 17 ECG-gated T1W “black blood”
TSE sequence
Transverse plane (no further information
provided)
Article focused on sev se series. n ¼ 1 with aortic dilatation,
which developed and ressed during imaging follow-up
Bondy 200680 101 ECG-gated T1W “black blood”
TSE sequence
Axial slice at level for ascending and descending
aorta at level of RPA
Growth hormone has fect on indexed aortic size
Matura 200740 166 ECG-gated T1W “black blood”
TSE sequence
Ascending and descending aorta at level of RPA 32% have ASI >2. 9.5% AD diameter >mean þ2 SD of
control population, 32 ve ASI >2, 45% have AD:DD >1.5
Lanzarini 200732 59 Five levels within the thoracic aorta and one in
the proximal abdominal aorta
Good correlation betw echo and CMR in ascending aorta,
however poorer corre in rest of aorta.
Sachdev 200822 15 ECG-gated T1W “black blood”
TSE sequence
Four locations in ascending aorta (annulus, sinus,
STJ, ascending aorta)
Aortic root dilated (in diameter >mean þ2 SD) in 25%
of patients with BAV ared with 5% of TAV
Cleeman 201081 41 3D SSFP at diastole Nine locations in thoracic aorta No dilatation in mean c diameter, however aortic dilatation
(indexed diameter >m þ2 SD of control group) was present
in n ¼ 5 in at least on he nine measured locations. Using
AD:DD, dilation was p t in 28% of TS and 32% of controls.
Hjerrild 201041,a 102 3D SSFP at diastole Eight locations in thoracic aorta 23% had aortic dilatio exed diameter >mean þ2 SD) in
at least one location, ilation in 2 locations in 14%. In
the latter group, 85% AV. Aortic diameter correlated
with age, sex, BP, and ence of CoA and BAV.
Mortensen 201052,a 99 3D SSFP at diastole Eight locations in thoracic aorta TS have 6.7X RR of as ng aortic dilation compared to the
general population. A ing aorta dilation associated with
BAV and aortic coarct and 45X monosomy.
Kim 201182 51 MRA Nine locations in thoracic aorta Ascending aorta dilat was common, with 30% with
dilated aortic sinus (in d diameter >mean þ2 SD). 40.8%
had AD:DD >1.5.
Mortensen 201124,a 80 3D SSFP at diastole Nine locations in thoracic aorta at baseline
and 2 yrs follow-up
At a mean follow-up  0.4 yrs, increased dilatation was
seen in the aortic sinu otubular junction and mid-ascending
aorta. Mean growth r 1e0.4 mm/yr. BAV associated with
more rapid growth ra n TAV (0.44  0.57 versus 0.18 
0.61 mm/yr/m2)
Mortensen 201344,a 102 3D SSFP at diastole Eight locations in thoracic aorta at baseline,
2 yrs and 5 yrs
Signiﬁcant growth see ascending but not descending aorta.
Growth rates varied f .20  0.34 to 0.38  0.46 mm/yr for
the three most proxim cending aorta measurements. Age,
CoA, BAV were associ ith an accelerated growth while
diastolic BP and hype ve treatment were associated with
slower growth
(continued on next page)
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A. Marin et al. / Clinical Radiology 70 (2015) 803e814808the ascending aortic diameter. Using this measure, a ratio
>1.5 is indicative of ascending aorta dilatation.39 However,
this can be true only if the descending aorta diameter is
normal. Another alternative, which correlates more closely
with aortic diameter, is the use of the body surface area
(BSA), and calculation of the ascending aortic size index
(ASI) using the calculation: aortic diameter/BSA. The latter
is more accurate in the assessment of aortic dilatation and
the prediction of aortic dissection, with an ASI 2 cm/m2
considered as aneurysmal, with a higher risk of future
growth and/or dissection requiring close surveillance (an
example is the patient shown in Fig 4), while an ASI
2.5 cm/m2 poses an extremely high risk and a need for
prompt surgical intervention.5,40 Recently, Mortensen
et al.44 have derived a mathematical model that uses cur-
rent aortic dimensions, presence of BAV, aortic coarctation,
diastolic blood pressure, and BSA to predict those with a
high risk of rapid progression of aortic dilatation.44 How-
ever, this has yet to be externally validated in a prospective
study.
MRI is inarguably the optimal method for assessment of
the thoracic aorta. However, the precise choice of technique
varies from centre to centre. A 2007 guideline on the
management of TS suggested that the aorta should be
measured in end-systole. This is readily achievable using a
black blood turbo spin-echo (TSE) sequence, although this
suffers from only measuring a single point of the aorta, and
changes in slice angulation can lead to overestimation of
diameter. Alternatively, a respiratory navigated, electrocar-
diogram (ECG)-gated three-dimensional (3D) steady-state
free-procession (bSSFP) technique will provide images of
the entire thoracic aorta in diastole, allowing accurateFigure 4 An oblique coronal left ventricular outﬂow tract cine image
(bSSFP) end diastolic frame of a 50-year-old patient with TS. Right top
ﬁgure (white frame) shows a normal tricuspid aortic valve (white
arrow) in this patient. Measurements of the annulus (A), sinus of
Valsalva (SV), sinotubular junction (STJ), and ascending aorta (AA)
were within the normal limits for an adult patient: 20, 27, 22, and
32mm, respectively. However, the calculated ASI was 2.28 cm/m2
(body surface area ¼ 1.4m2) indicating a higher risk of future growth
and/or dissection.
Figure 5 Volume-rendered MR aortography in a TS patient with
previous aortic dissection and the residual coarctation (white arrow)
and aortic aneurysm of descending thoracic aorta (white arrowhead)
following surgical repair.
A. Marin et al. / Clinical Radiology 70 (2015) 803e814 809measurement of the aortic root as well as the ascending and
descending aorta, although this comes at a cost of a
signiﬁcantly prolonged acquisition time.45
The data underpinning our understanding of aortic
dissection in TS is extremely limited (Table 2). What is well
established is that TS is associated with an elevated risk of
developing aortic dissection and that dissections occur at a
much earlier age. The incidence of aortic dissection is esti-
mated to be as much as 100-fold higher in TS compared to
the general population, although this value was based on
only three dissections in a population of 166 females with
TS.40 A more conservative estimate is a six-times increase in
relative risk in a study by Gravholt et al.,9 although this
compared the TS cohort with an unmatched population rate
and is, therefore, likely extremely conservative. Most strik-
ing is the early age at which TS patients develop dissection,
with a mean age of 30.5 years (interquartile range [IQR]
23.5e38.5), compared with a mean age in the general fe-
male population of 77 years.46 It is estimated that at least
1.4% of females with TS will suffer an aortic dissection.9
One or more predisposing cardiovascular risk factors
(BAV, aortic dilatation, and aortic coarctation) can be iden-
tiﬁed with cardiovascular imaging in up to 90% of aortic
dissections in TS.9,13,15 Hypertension is also strongly asso-
ciated with aortic dilatation and dissection, while upper
extremity hypertension is a hallmark of signiﬁcant aortic
coarctation. However, aortic dilatation occurs at an early
age in BAV and cannot thus be attributed solely to hyper-
tension.47 Finally, pregnancy in TS appears to be associated
with a high risk of dissection.48 In those who do dissect
during pregnancy, prognosis is extremely poor with an 86%
mortality in one series.49 Thus, careful cardiac and thoracic
screening is essential in all those considering assisted
contraception or pregnancy, with some experts advising an
ASI >2 cm/m2 to be a contraindication to pregnancy.50
Identiﬁcation and intervention in high-risk individuals is
challenged by the difﬁculty in deﬁning a dilated aorta as
mentioned before. In a study by Matura et al.,40 all patients
with dissection had an ASI >2.5, while two-thirds had
AD:DD >1.5. In a study by Carlson et al.46 the mean ASI was
2.7  0.6 cm/m2 in those with dissection, with two out of
the 10 dissections occurring in patients with ASI <2.5 cm/
m2, although the measurements were with echocardiogra-
phy and taken up to 6 years prior to the dissection. In a
study cohort of 166 TS patients, it was shown that dissection
occurred in 25% with AD >3.5 cm, 33% of those with ASI
>2.5, and only 3% with AD:DD >1.5, suggesting ASI as the
most useful indicator of a dilated aortawith requirement for
urgent intervention when a threshold of 2.5 cm/m2 is
reached. Although MRI is the technique of choice in the
screening and follow-up of those at risk for dissection,
computed tomography (CT) angiography is typically the
technique of choice in the acute assessment of those pre-
senting with symptoms of dissection due to its wide avail-
ability and speed. Ideally, CT aortography should be
performedwith ECG gating due to improved visualisation of
the proximal ascending aorta.51
Aortic coarctation affects 12% of women with TS.12
Additionally, elongated transverse arch and kinking of theisthmic portion of aorta can be seen in around half of all TS
cases (Figs 5 and 6).12,52 This is likely part of a spectrum of
abnormalities affecting the thoracic aorta, with elongated
transverse arch as the mildest expression, and aortic arch
hypoplasia/aplasia representing the most severe end of the
spectrum, observed in around 2% of TS females.52 Aortic
coarctation has been shown to be associated with dissec-
tion, and it has been proposed that elongated transverse
arch may similarly predispose to dissection due to
abnormal ﬂow velocities and shear stress within the arch,
although this has not been properly evaluated.12 Aortic
coarctation is well evaluated with MRI, using either MR
angiography (MRA) or a 3D bSSFP sequence, with both
techniques showing a tight stenosis at the aortic isthmus
with or without collateral formation. Current guidelines of
European Society of Cardiology suggest intervention when
there is >50% stenosis at the coarctation compared to the
aortic diameter at the diaphragm with hypertension (Class
IIa recommendation) with consideration to intervene even
in the absence of hypertension (Class IIb recommenda-
tion).53 Additional functional assessment can be performed
with velocity-encoded cine-MRI. Indicators of signiﬁcant
ﬂow impairment include: greater ﬂow through the distal
thoracic aorta than through the thoracic aorta immediately
distal to the coarctation; retrograde intercostal artery ﬂow;
and a diastolic tail with loss of the normal systo-
licediastolic variation in ﬂow. A pressure gradient across
the stenosis can be calculated using the modiﬁed Bernoulli
equation (DP ¼ 4v2) where v is the maximum velocity
through the coarctation. A gradient above 15 mmHg has
been suggested as being signiﬁcant on MRI, whereas
echocardiography uses a threshold of 20 mmHg, which is
similar to that used in invasive catheter measurements,
although MRI often underestimates the peak velocity,
hence the discrepancy.53,54 However, signiﬁcant collateral
ﬂow can result in the pressure gradient being artiﬁcially
Figure 6 Sagittal oblique cine SSFP image of a 55-year-old TS patient
showing a high-riding aorta (white arrow), residual coarctation after
surgical repair (white arrowhead), and dilatation of ascending aorta
(white dashed arrow), with the ASI >2.5.
A. Marin et al. / Clinical Radiology 70 (2015) 803e814810low, and thus, quantiﬁcation of collateral ﬂow is considered
a more accurate assessment of the haemodynamic signiﬁ-
cance of the stenosis.55
Partial anomalous pulmonary venous return is the most
common venous anomaly and is found in 13% of TS cases,
compared with w1% of the general population. This can
present with right heart failure or pulmonary hypertension
due to left to right shunting causing right ventricular and
pulmonary volume overload.56 Careful scrutiny is impor-
tant in cross-sectional imaging as visualisation of the pul-
monary veins can be particularly challenging using
transthoracic echocardiography.57,58 Persistent left-sided
superior vena cava is also commonly found in TS (13%,
compared to 1% in the general population). This is usually
asymptomatic, but is important to report because it has the
potential to cause confusion during central venous or right
heart catheterisation, it may act as a route for paradoxical
emboli when it inserts into the left atrium, and can cause
complications in cardiothoracic surgery.59 A simple half-
Fourier acquisition single-shot turbo spin-echo (HASTE)
stack is often sufﬁcient to visualise these anomalies. How-
ever, MRA or 3D bSSFP can also be useful to provide further
visualisation of the vessels in case of uncertainty.
Other congenital cardiovascular disorders that can be
observed in TS are ventricular septal defects, hypoplastic
left heart syndrome, single ventricle, mitral valve abnor-
malities, atrial septal defects, coronary artery abnormalities,
and aberrant right subclavian artery.14 In the retrospective
review by Cramer et al.,14 two TS patients out of 173 had
coronary artery abnormalities: one patient had an anoma-
lous left coronary artery from the pulmonary artery, and the
other patient had a small coronary artery ﬁstula from the
left coronary artery to the pulmonary artery. The risk for
coronary artery disease is higher in TS women when
compared to the general population.60 Women with TSmore often have higher values of body mass index and
waist:hip ratio, higher values of diastolic blood pressure,
and higher levels of total cholesterol and low-density li-
poprotein fraction, whereas levels of the high-density li-
poprotein fraction are lower. Cardiac imaging in women
with TS also reveals an increased left ventricular mass in
association with aortic valve disease, age, hypertension,
physical stature, and metabolic status.61,62The imaging techniques
Transthoracic echocardiography is the imaging method
of choice in the initial assessment of the cardiovascular
system in the neonate, toddler, and young girl with TS. It
provides an accurate and reliable non-irradiating assess-
ment of the cardiovascular anatomy, including the root and
the ascending part of the thoracic aorta and the entry of the
pulmonary veins into the left atrium.32 However, in ado-
lescents and adults, the shape of the thorax in TS can lead to
suboptimal echocardiography images.39 In addition, trans-
thoracic echocardiography is also limited in visualising the
left upper pulmonary vein, and poor at visualisation of the
thoracic aorta distal to the ascending portion.12,63,64 It has
been generally accepted that a thorough characterisation of
the cardiovascular anatomy is necessary at the time of TS
diagnosis.58 Transthoracic echocardiography enables iden-
tiﬁcation of the life-threatening cardiovascular disorders
and their complications in the majority of children with TS.
Although transthoracic echocardiography remains a stan-
dard follow-up investigation in many centres due to its
availability and relatively low cost, in the case of incomplete
or suboptimal visualisation of cardiovascular anatomy with
echocardiography, or in the case of clinical indication, MRI
should be performed.22,39 The importance of screening in
younger age groups needs to be stressed because aortic
dilatation can occur in girls as young as 5 years of age.13,65,66
At the age of 12 years, when most children would tolerate
an MRI procedure without sedation, thoracic MRI should be
performed.67 An imaging protocol has been previously
proposed by Turtle et al.8 (Fig 7), which should be imple-
mented at the transition to adulthood (around 16 years of
age).
MRI provides a ionising radiation free and non-invasive
assessment of cardiovascular anatomy with good visual-
isation of the heart chambers, myocardium, and the valves
and a clear visualisation of the entire thoracic aorta,
enabling recognition of the clinically and sonographically
silent anomalies, such as a mild dilatation of the aorta or an
elongation of the transverse aortic archwith kinking.32,39 As
mentioned previously, MRI can supplement transthoracic
echocardiography in cases of inadequate visualisation of the
aortic valve leaﬂets and combination of both imaging
methods yields diagnostic visualisation of the valve in
almost all cases.22
In certain clinical conditions, there is a role for ECG-gated
CT aortography in imaging of the acute aortic syndrome,
and occasionally CT coronary angiography may be of use in
the investigation of chest pain, particularly given the
All girls at the age of 12 years
diagnosed at age
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Figure 7 A summary of recommended cardiovascular system imaging in patients with TS. (The grey highlighted section is adapted with
permission from Turtle et al.8) (a) When aortic dissection and/or coarctation is clinically suspected. (b) When MRI is not available or contra-
indicated. (c) When second transthoracic echocardiography is non-contributable. (d) When MRI can be without general sedation.
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gated CT angiography is the diagnostic method of choice
in the setting of suspected aortic dissection in TS patients,
clearly demonstrating the intimal ﬂap, as well as the entry
and re-entry sites and branch vessel involvement. This al-
lows for prompt and accurate assessment on which to plan
subsequent management strategies. Non-ECG-gated CT
angiography can be used when ECG gating is not available,
but it must be performed with the knowledge that small
type A dissection ﬂaps can be both under- and over-called
due to movement artefact at the aortic root.51 In addition,
the excellent spatial resolution and ease of multiplanar
reformatting of CT angiography make it an excellent tool for
assessing the anatomical structure of both the heart, pul-
monary venous drainage, valve structure, and thoracic
aorta, particularly where MRI is not available or contra-
indicated, although the associated radiation dose in a
typically young population make this suboptimal for long-
term follow-up.68Discussion
A review of the literature on TS has demonstrated that
cardiovascular disorders are a major factor in the higher
SMR of these patients compared to the general population.
More troublesome is the early age at which TS patients can
develop life-threatening cardiovascular complications. It is
generally accepted that at the time of diagnosis of TS,
echocardiography should be routinely performed as a part
of a full cardiovascular evaluation. The review also dem-
onstrates that thorough imaging of the aortic valve and the
thoracic aorta are essential. Although, the speciﬁc timing of
screening and follow-up are as yet undetermined, Fig 7
summarises our recommendations for a long-term cardio-
vascular imaging programme for patients with TS.Conclusion
Turner’s syndrome is associated with high mortality
from cardiovascular disorders. Awareness of the common
ﬁndings in Turner’s, in combination with a structured
approach to imaging and follow-up, will provide maximum
yield in terms of early identiﬁcation and management of a
wide range of potentially serious cardiovascular conditions.Acknowledgements
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